Novel Coronavirus 2019 (COVID-19)

The Osteopathic Medical Board remains open as we perform essential governmental functions to license and regulate osteopathic physicians and surgeons who are on the front lines of the Coronavirus (COVID-19) pandemic. Should you experience any delays in reaching staff during this time, we appreciate your patience and apologize for any inconvenience in advance.

Alert Alert:

New: AB 2113 - Expedited Licensure for Refugee Status Outreach

New: Notice Regarding COVID-19 Vaccine Administration

New: Prescribing and Reporting Rules for Controlled Substances Effective January 1, 2021

New: AB 149 - New requirements for controlled substances prescription forms

New: Emergency Medical Services Authority (EMSA) - Waivers

The Osteopathic Medical Board would like to notify you that the Cybersecurity & Infrastructure Security Agency, Federal Bureau of Investigation, and the Department of Health and Human Services have credible information of an increased and imminent cybercrime threat to U.S. hospitals and healthcare providers. The Osteopathic Medical Board is sharing this information to provide warning to healthcare providers to ensure that they take timely and reasonable precautions to protect their networks from these threats. Please see additional information at the Cybersecurity & Infrastructure Security Agency website: https://us-cert.cisa.gov/ncas/alerts/aa20-302a.

Department of Health Care Services to all health care licensees

Essential versus Non-Essential Services

Notice to Stakeholders Novel Coronavirus 2019 (COVID-19)

CDPH What You Need To Know: Novel Coronavirus 2019 (COVID-19)

New: EXCITING OPPORTUNITY: Apply to become an Expert Reviewer

Apply for Board appointments here

CURES Mandatory Use Begins October 2, 2018

Mission Statement

To protect consumers and promote the highest professional standards in the practice of osteopathic medicine, the Osteopathic Medical Board of California licenses osteopathic physicians and surgeons.

The board investigates consumer complaints and uses its enforcement power to ensure practitioners abide by the provisions of the state Business and Professions Code/Medical Practice Act.

To maintain their license, practitioners must successfully complete rigorous, periodic continuing education requirements that meet the standards of the American Osteopathic Association (AOA).

CURES

The Controlled Substance Utilization Review and Evaluation System (CURES) was certified for statewide use by the Department of Justice on April 2, 2018. Therefore, the mandate to consult CURES prior to prescribing, ordering, administering, or furnishing a Schedule II-IV controlled substance becomes effective on October 2, 2018.

CURES contains the following information: patient name, patient date of birth, patient address, prescriber name, prescriber DEA number, pharmacy name, pharmacy license number, date prescription was dispensed, prescription number, drug name, drug quantity and strength, and number of refills remaining.